Re-emergent tremor provocation
Objective: to evaluate the effect of tremor provocation on re-emergent tremor latency and variability. Background: Rest and re-emergent tremor (RET) in Parkinson’s disease (PD) are…Cerebellar Ataxia in Patients with Huntington’s Disease, an underestimated symptom?
Objective: To analyze the prevalence of cerebellar ataxia in patients with Huntington’s Disease (HD), both early and late on HD progression and correlating the degree…Huntington’s disease: A case review of Sub-Saharan Africans with diverse origins
Objective: To characterise the Huntingtons disease phenotype in Sub-saharan Africans. Background: Huntington’s disease (HD) is a debilitating neurodegenerative illness that leads to diminished cognitive function,…Digital monitoring of Huntington’s disease with smartphone and smartwatch wearable technology: The Digital-HD study
Objective: To investigate the tolerability and feasibility of using wearable smartphone and smartwatch technologies to monitor the motor, behavioural, cognitive and quality of life (QoL)…Long-term apomorphine infusion (APO) users versus short-term APO users: What is the reason to discontinue therapy? A multi-centre study
Objective: To evaluate the long-term efficacy of APO in PD patients treated at two specialist centres in Spain and Thailand, and to determine the reasons…Incidence of treatment-emergent adverse events in Parkinson’s disease patients according to race: post-hoc analysis from double-blind combined BIPARK-I and II data.
Objective: To evaluate the incidence of treatment-emergent adverse events (TEAEs) in levodopa-treated Parkinson’s Disease (PD) patients with motor fluctuations and taking opicapone (OPC). Background: OPC…Deep Brain Stimulation in Early-Stage Parkinson’s Disease Provides Long-Term Rest Tremor Benefit Through Five Years
Objective: To analyze symptomatic control of rest tremor five years after randomization in the deep brain stimulation (DBS) in early-stage Parkinson’s disease (PD) pilot clinical…Gocovri Dose Adjustment in Elderly Parkinson’s Patients at Risk for Renal Impairment: Implications from an Exposure Simulation Model
Objective: Evaluate amantadine exposure following Gocovri® (amantadine) extended release capsules dosing regimens in renal impairment, using pharmacokinetic (PK) modeling and simulations. Background: Gocovri bedtime dosing…Practice Patterns with Onabotulinum Toxin-A for Movement disorders: South Asian Neurologist Survey
Objective: To understand physicians’ barriers in management of movement disorders (MD) with Onabotulinumtoxin-A (OnabotA). Background: OnabotA effectiveness for treating MD is well known. However, from…Hemiballismus-hemichorea due to ischemic stroke
Objective: Describe an unsual cause of movements disorders . Background: Hemiballismus-hemichorea is a rare and debilitating presentation of subcortical stroke. Method: We describe a case…
- « Previous Page
- 1
- …
- 186
- 187
- 188
- 189
- 190
- …
- 217
- Next Page »